This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The FDA has authorized Vitestro's Aletta system, the first standalone robotic device for ...
One minute and 49 seconds, that was the median time a machine needed to read a patient’s arm, choose a vein, insert a needle, fill the tubes, and withdraw, across the Dutch clinical trial that carried ...
Utrecht-based Vitestro has raised €20mn to bring its robotic blood drawing device to market. Founded in 2017, Vitestro aims to improve the blood draw experience for patients and address personnel ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The FDA has authorized Aletta, a robotic device designed for autonomous blood draws that ...
– Vitestro, the pioneering autonomous blood drawing company, today announced that it has raised $22 million (€20 million) funding to accelerate commercialization of its innovative robotic blood ...
In future, blood samples may be taken by an autonomous robot rather than a healthcare professional – if Dutch developer Vitestro can get its prototype approved for marketing. Vitestro's blood drawing ...
Hosted on MSN
This robot will draw your blood now
You sit down and put your arm in the cradle. You press a button. The machine takes it from there. A near-infrared light sweeps your inner elbow, hunting for a vein. A puff of alcohol hits your skin.
Labcorp Venture Fund, Mayo Clinic, Sutter Health, InterVest, MGFO, PGGM, Puma Venture Capital, and ROM Utrecht invest alongside existing investors Invest-NL, EIC Fund, Fred Moll, NYBC Ventures, and ...
Egyptian fruit bats flew more slowly after eating alcohol-laced food. Now the urine strips that caught boozy wild chimps may be used on wild bats. Teen Heart Health Scores Average 68.3 in Ninth Grade ...
Vitestro, a Netherlands-based medical robotics company developing autonomous blood-drawing technology, has raised $70 million in an oversubscribed Series B financing round to accelerate development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results